Sequana Medical N.V.

    Sequana Medical N.V.

    EEURONEXT:SEQUA
    - -
    EUR
    - -
    - -
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    Revenue per Share
    - -
    0.12
    0.11
    0.1
    0.08
    0.08
    0.06
    0.02
    0.04
    0.03
    - -
    Basic EPS, GAAP
    - -
    -0.85
    -1.02
    -0.6
    -1.02
    -1.22
    -1.25
    -1.3
    -1.35
    -1.22
    -1.22
    Free Cash Flow per Basic Share
    - -
    -0.83
    -0.95
    -0.61
    -0.73
    -1.51
    -1.12
    -1.31
    -1.24
    -1.11
    -0.55
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.21
    -0.02
    -0.49
    -0.34
    -1.37
    0.07
    0.01
    -0.04
    -0.09
    -0.69
    -1
    Tangible Book Value per Share
    0.21
    -0.02
    -0.49
    -0.34
    -1.37
    0.07
    0.01
    -0.04
    -0.09
    -0.69
    -1
    Basic Weighted Avg Shares
    - -
    14
    14
    14
    14
    12
    15
    18
    23
    27
    37
    Sales/Revenue/Turnover
    - -
    2
    1
    1
    1
    1
    1
    - -
    1
    1
    - -
    Operating Margin (%)
    - -
    -673.96
    -936.65
    -568.91
    -1,270.6
    -1,438.6
    -1,844.85
    -6,103.55
    -3,044.86
    -4,052.7
    -17,273.01
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    Net Income, GAAP
    - -
    -12
    -14
    -8
    -14
    -15
    -19
    -24
    -31
    -33
    -45
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    -685.89
    -938.67
    -630.78
    -1,358.69
    -1,543.05
    -1,983.45
    -6,373.84
    -3,334.08
    -4,572.42
    -42,325.7
    Working Capital
    3
    - -
    -1
    -2
    -16
    3
    7
    6
    8
    -13
    -47
    LT Debt
    - -
    - -
    5
    2
    3
    3
    8
    8
    13
    9
    - -
    Total Equity
    3
    - -
    -7
    -5
    -19
    1
    - -
    -1
    -2
    -19
    -44
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    -3,678.89
    - -
    - -
    - -
    - -

    Capital Structure

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    252.33%
    43.99%
    127.99%
    Free Cash Flow
    - -
    4.72%
    -31.64%
    Net Income, GAAP
    - -
    24.88%
    37.13%
    Sales/Revenue/Turnover
    - -
    -4.25%
    -85.19%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    1
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    -1.22
    2024
    - -
    - -
    - -
    - -
    -1.22
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business